Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect
Findings seen despite negligible remaining lebrikizumab serum concentrations following treatment withdrawal
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.